Kailash P Bhatia Selected Research

Atrophy

1/2022	Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism.
3/2016	The clinical syndrome of dystonia with anarthria/aphonia.
2/2015	Atypical parkinsonism: diagnosis and treatment.
6/2010	ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.
1/2009	Characterization of PLA2G6 as a locus for dystonia-parkinsonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kailash P Bhatia Research Topics

Disease

59	Dystonia (Limb Dystonia) 01/2023 - 01/2004
33	Parkinson Disease (Parkinson's Disease) 10/2021 - 09/2004
31	Parkinsonian Disorders (Parkinsonism) 02/2023 - 05/2003
28	Movement Disorders (Movement Disorder) 05/2024 - 07/2004
15	Tremor (Tremors) 11/2023 - 12/2005
15	Dyskinesias (Dyskinesia) 01/2022 - 06/2003
15	Torticollis (Wryneck) 05/2021 - 01/2002
10	Chorea (Rheumatic Chorea) 10/2021 - 05/2008
9	Dystonic Disorders (Writer's Cramp) 07/2013 - 06/2003
7	Myoclonus (Nocturnal Myoclonus) 01/2024 - 12/2009
7	Myoclonic dystonia 11/2019 - 10/2002
6	Disease Progression 02/2022 - 08/2010
5	Atrophy 01/2022 - 01/2009
5	Essential Tremor (Essential Tremors) 01/2021 - 09/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 01/2013
4	Neuroferritinopathy 03/2017 - 02/2005
4	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 01/2017 - 01/2009
4	Dystonia musculorum deformans type 1 09/2016 - 01/2004
4	Dopa-responsive Dystonia 12/2015 - 06/2009
3	Corticobasal Degeneration 04/2024 - 02/2015
3	Tauopathies 04/2023 - 07/2014
3	Huntington Disease (Huntington's Disease) 10/2021 - 12/2004
3	Cerebellar Ataxia (Dysmetria) 01/2021 - 08/2016
3	Nervous System Diseases (Neurological Disorders) 01/2018 - 01/2013
3	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 03/2017 - 09/2010
3	Migraine Disorders (Migraine) 01/2017 - 06/2008
3	Ataxia (Dyssynergia) 09/2015 - 07/2014
3	Neurodegeneration with brain iron accumulation (NBIA) 04/2013 - 11/2010
3	Hepatolenticular Degeneration (Wilson's Disease) 09/2012 - 11/2010
2	Seizures (Absence Seizure) 01/2022 - 01/2017
2	Fabry Disease (Fabry's Disease) 08/2021 - 01/2021
2	Cognitive Dysfunction 01/2021 - 09/2010
2	X-Linked Torsion Dystonia 3 01/2021 - 11/2010
2	Mental Disorders (Mental Disorder) 10/2020 - 01/2018
2	Tardive Dyskinesia 12/2019 - 12/2004
2	Tic Disorders (Tic Disorder) 01/2019 - 10/2004
2	Tourette Syndrome (Tourette's Syndrome) 01/2019 - 12/2004
2	Task-Specific Focal Dystonia 01/2018 - 06/2007
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2018 - 08/2016
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2018 - 04/2008
2	Epilepsy (Aura) 01/2017 - 06/2008
2	Channelopathies 01/2017 - 06/2009
2	Brain Diseases (Brain Disorder) 08/2016 - 06/2012
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 02/2015 - 01/2006
2	Hypokinesia (Bradykinesia) 06/2014 - 04/2010
2	Dystonia 18 03/2014 - 11/2002
2	Cataplexy 12/2013 - 12/2011
2	Narcolepsy 12/2013 - 12/2011
2	Fibrosis (Cirrhosis) 09/2012 - 07/2012

Drug/Important Bio-Agent (IBA)

26	Levodopa (L Dopa)FDA LinkGeneric 02/2023 - 06/2003
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2012
13	IronIBA 01/2022 - 07/2004
10	Botulinum Toxins (Botulinum Toxin)IBA 08/2021 - 01/2006
9	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2023 - 11/2007
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2003
8	AntibodiesIBA 01/2021 - 10/2004
8	Dopamine (Intropin)FDA LinkGeneric 10/2020 - 03/2010
5	Sarcoglycans (beta Sarcoglycan)IBA 11/2019 - 10/2002
4	Ion Channels (Ion Channel)IBA 01/2023 - 12/2012
4	Type A Botulinum Toxins (Botox)FDA Link 05/2021 - 10/2006
4	ManganeseIBA 11/2016 - 07/2012
4	Leucine (L-Leucine)FDA Link 08/2016 - 01/2005
3	1,3-dipropyl-8-phenylxanthineIBA 01/2024 - 08/2016
3	EnzymesIBA 01/2022 - 12/2015
3	Antipsychotic Agents (Antipsychotics)IBA 10/2020 - 05/2015
3	Therapeutic UsesIBA 01/2019 - 08/2011
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 03/2016
3	Anticonvulsants (Antiepileptic Drugs)IBA 06/2016 - 09/2006
2	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2023
2	Potassium Channels (Potassium Channel)IBA 05/2022 - 09/2015
2	TEMPOIBA 02/2022 - 08/2021
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2021 - 01/2021
2	incobotulinumtoxinA FDA Link 05/2021 - 01/2020
2	CalciumIBA 01/2021 - 04/2015
2	Dopamine Receptors (Dopamine Receptor)IBA 10/2020 - 12/2019
2	AutoantibodiesIBA 01/2020 - 01/2018
2	Calcium Channels (Calcium Channel)IBA 11/2019 - 05/2011
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 09/2019 - 01/2018
2	amphiphysinIBA 01/2018 - 08/2016
2	tributyl phosphate (TBP)IBA 01/2018 - 04/2008
2	Glycine Receptors (Glycine Receptor)IBA 01/2018 - 08/2016
2	Familial apoceruloplasmin deficiencyIBA 03/2017 - 06/2012
2	Histone MethyltransferasesIBA 02/2017 - 01/2017
2	Guanosine Triphosphate (GTP)IBA 12/2015 - 09/2014
2	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 05/2015 - 09/2014
2	SynucleinsIBA 09/2014 - 12/2012
2	salicylhydroxamic acid (SHAM)IBA 09/2014 - 09/2014
2	OrexinsIBA 12/2013 - 12/2011
2	Isoleucine (L-Isoleucine)FDA Link 04/2013 - 06/2011
2	Peptides (Polypeptides)IBA 04/2013 - 07/2007
2	AcidsIBA 02/2013 - 06/2011
2	MetalsIBA 01/2013 - 09/2012
2	pantothenate kinaseIBA 04/2012 - 11/2010

Therapy/Procedure

16	Deep Brain Stimulation 05/2022 - 10/2006
13	Therapeutics 04/2023 - 01/2002
11	Transcranial Magnetic Stimulation 01/2019 - 12/2003
8	Injections 08/2021 - 01/2006
3	Transcranial Direct Current Stimulation 11/2023 - 09/2014
3	Immunotherapy 01/2021 - 01/2020
2	Pallidotomy 12/2019 - 03/2007